fitness to drive (cardiac)
in review
6 min read
Updated 2026-10-22
CCS 2023 sets driving limits by the annual risk of sudden cardiac incapacitation (SCI): ≤22%/year acceptable for private drivers, ≤1%/year for commercial. Short post-event stand-downs (after ACS, PCI, CABG, devices) are expert consensus for transient risk, not the formula. With more than one condition, the most restrictive rule applies. Restrictions run from the procedure date, or from discharge if no intervention. Volatile detail → check the current CCS guideline and provincial rules.
risk of harm formula
- Benchmark: a commercial driver with 1% annual SCI risk → 1 in 20,000/year risk of death or serious injury to others
- Private drivers spend less time driving, in smaller vehicles → same societal harm at 22% annual SCI risk
- Commercial = any commercial licence class (trucks, buses, taxis), not only tractor-trailers
coronary disease
| condition | private | commercial |
|---|---|---|
| STEMI or NSTEMI + PCI, LVEF >40% | 2 weeks | 1 month |
| STEMI or NSTEMI + PCI, LVEF ≤40% | 1 month | 3 months |
| STEMI or NSTEMI, no PCI | 1 month | 3 months |
| unstable angina + PCI | 48 h | 7 days |
| unstable angina, no PCI | 7 days | 1 month |
| elective PCI | 48 h | 48 h |
| CABG | 1 month | 3 months |
| stable angina or asymptomatic CAD | no restriction | no restriction |
- Untreated left main stenosis disqualifies: ≥50% commercial, ≥70% private
- ACS with non-obstructive coronaries → treat as revascularised; LVEF drives the decision → MINOCA
- Ongoing LV dysfunction → HF rules below; ICD → device rules. Post-MI management → post-MI care
heart failure, LVAD, transplant
| condition | private | commercial |
|---|---|---|
| NYHA I–II | no restriction | disqualified if LVEF <30% |
| NYHA III | no restriction | disqualified |
| NYHA IV | disqualified | disqualified |
| intermittent outpatient or home inotropes | disqualified | disqualified |
| LVAD | ≥2 months post-implant + NYHA I–II | disqualified |
| heart transplant | ≥6 weeks post-discharge, NYHA I–II | ≥6 months, NYHA I, LVEF ≥50% |
- applies to all LVEF phenotypes → HFrEF management
valvular disease
Untreated (medically managed):
| lesion | private: drive if | commercial: drive if |
|---|---|---|
| AS | NYHA I–II | NYHA I, no impaired consciousness, LVEF ≥50% |
| AR, MR, MS, TR | NYHA I–III | NYHA I, no impaired consciousness, LVEF ≥50% (except MS) |
- symptomatic severe AS (NYHA III–IV) → no private driving until treated → aortic stenosis
After intervention:
| procedure | private | commercial |
|---|---|---|
| TAVI (AS or AR) | 1 month | 3 months |
| valve surgery | 1 month | 3 months |
| TEER; balloon mitral valvuloplasty | 48 h | 1 month |
- commercial after any valve intervention: NYHA I and LVEF ≥30%
- after TAVI/AVR: no new high-grade AV block unless paced
arrhythmias
ventricular arrhythmias
| condition | private | commercial |
|---|---|---|
| VF without reversible cause | 3 months | disqualified |
| unstable VT, or VT with impaired consciousness | 3 months | disqualified |
| sustained VT, structural heart disease, conscious, no ICD | 3 months | disqualified |
| sustained idiopathic VT (normal heart), conscious | 1 week once controlled | disqualified |
| VT/VF from reversible cause (VF <24 h of MI, during angiography, electrocution, drug toxicity) | until cause treated | until cause treated |
ICD whenever indicated → ventricular arrhythmias and sudden cardiac death
SVT, AF, flutter
- No impaired consciousness → no restriction (both classes)
- With impaired consciousness → disqualified until satisfactory control
- After EP study or ablation → 48 h if no new conduction disturbance or arrhythmia
- Acute management → approach to tachyarrhythmias, atrial fibrillation
bradycardia and conduction disease
Asymptomatic conduction disease → no restriction for either class: first-degree AVB, isolated RBBB/LAFB/LPFB, LBBB, bifascicular block (± first-degree AVB), Mobitz I, congenital complete heart block. Any impaired consciousness → disqualified until device therapy.
Disqualified (both classes) until pacemaker:
- Mobitz II, alternating BBB, acquired complete heart block (or resolution of a reversible cause, e.g. inferior STEMI, Lyme carditis)
- Sinus node dysfunction with impaired consciousness
- Symptomatic pauses ≥5 s in AF or on conversion
Pacing indications → bradyarrhythmias and pacemakers.
pacemakers and ICDs
pacemakers
| situation | private and commercial |
|---|---|
| new pacemaker (transvenous or leadless) after impaired consciousness or high-grade AVB | 1 week |
| new pacemaker, no impaired consciousness or high-grade AVB | no restriction |
| generator change | no restriction |
ICDs (transvenous or subcutaneous)
Commercial driving: disqualified with any ICD, because of the underlying condition (LV dysfunction, VA history), not the device.
| situation | private |
|---|---|
| primary prevention | 1 week after implant |
| secondary prevention: VF, or VT with impaired consciousness | 3 months after last incapacitating event |
| secondary prevention: sustained VT, conscious | 1 week after implant |
| appropriate shock, disabling (or unknown, e.g. during sleep) | 3 months |
| appropriate shock, not disabling | 1 week |
| inappropriate therapy; generator change | no restriction |
inherited arrhythmia syndromes and cardiomyopathies
- private: no restriction if asymptomatic; 3 months after arrhythmic syncope, cardiac arrest or sustained VA (ICD doesn’t change this)
- commercial: individual expert assessment — high-risk features (syncope, arrest, HCM high-risk markers, definite ARVC, LQTS with QTc >500 or syncope) usually disqualify
- gene-positive relatives without disease → no restriction
- HCM risk stratification → hypertrophic cardiomyopathy
syncope
| situation | private | commercial |
|---|---|---|
| vasovagal, single or recurrent | no restriction | no restriction |
| reversible or treated cause (orthostatic, haemorrhage, dehydration) | 1 week | 1 month |
| situational with avoidable trigger (micturition, defecation) | 1 week | 1 month |
| unexplained, single | 1 week | 12 months |
| unexplained, recurrent within 12 months | 3 months | 12 months |
| arrhythmic, or diagnosed and treated | per arrhythmia and device rules | per arrhythmia and device rules |
- Workup → syncope; treatment → reflex syncope and orthostatic hypotension
other conditions
- Aortic aneurysm: not covered by CCS 2023 → size limits (CCS 2014) in aortic aneurysm
reporting
- Ontario: physicians, NPs and optometrists must report conditions causing sudden incapacitation (among other categories) to MTO under Highway Traffic Act s.203, using the Medical Condition Report. A mandatory report → licence suspension. Discretionary reports of other unsafe conditions do not automatically suspend. Telling the patient beforehand is encouraged; consent is not required → MTO medical reporting
- Document the advice given (stop driving, duration) in the chart
- Duty to report, counselling and non-cardiac conditions: CMA Driver’s Guide
Prepared 2026-10-22. Not yet verified — check every number against the sources.